Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-FR Version v2-EN
Language French English
Date Updated 2017-07-19 2017-07-19
Drug Identification Number 00583405 00583405
Brand name PEDIAZOLE PEDIAZOLE
Common or Proper name erythromycin ethylsuccinate and sulfisoxazole acetyl for oral suspension USP erythromycin ethylsuccinate and sulfisoxazole acetyl for oral suspension USP
Company Name AMDIPHARM LIMITED AMDIPHARM LIMITED
Ingredients SULFISOXAZOLE ERYTHROMYCIN SULFISOXAZOLE ERYTHROMYCIN
Strength(s) 600MG 200MG 600MG 200MG
Dosage form(s) POWDER FOR SUSPENSION POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 105 mL, 150 mL and 200 mL 105 mL, 150 mL and 200 mL
ATC code J01RA J01RA
ATC description COMBINATIONS OF ANTIBACTERIALS COMBINATIONS OF ANTIBACTERIALS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2017-07-18 2017-07-18
Actual discontinuation date 2017-07-18 2017-07-18
Remaining supply date 2017-07-18 2017-07-18
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments